Document is current

Article History

Accepted: 8 May 2025

First Online: 28 May 2025

Declarations

:

: All procedures were approved by the Institutional Review Board at the University of Colorado Boulder (Protocol #: 16–0056).

: Recruiting advertisements were posted/run on social media, mailed flyers, and local radio stations. During an initial phone interview, participants were screened for the inclusion criteria. Before asking any eligibility questions, interviewers obtained verbal consent from the potential participant. Given that the phone screen presented no more than minimal risk of harm and involved no procedures for which written consent is typically required outside of the research study, the study team was granted a waiver of written consent for the phone screen portion of the study. Eligible participants arrived at the laboratory for their first session, were taken to a private room, and were provided with a copy of the informed consent document. Before asking the participant to sign the consent form, the trained interviewer/research assistant discussed the study with the participant and asked if there were any questions they may have about the study. Participation will be clearly stated as voluntary, with the option to withdraw at any time. After discussing the study and reviewing the consent form, those still interested initialed and signed the informed consent document.

: The authors declare no competing interests.

: This clinical trial was registered on Clinicaltrials.gov under registration number NCT02994043:

: No artificial intelligence tools were used to prepare this manuscript.